Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Outcomes following hematopoietic cell transplantation for Wiskott–Aldrich syndrome

Bone Marrow Transplantation volume 47, pages 1428–1435 (2012)Cite this article

Subjects

Abstract

HLA-identical sibling donor transplantation remains the treatment of choice for Wiskott–Aldrich Syndrome (WAS). Since 1990, utilization of alternative donor sources has increased significantly. We report the hematopoietic cell transplantation (HCT) outcomes of 47 patients with WAS treated at a single center since 1990. Improved outcomes were observed after 2000 despite the increased number of alternative donors. Five-year OS improved from 62.5% (95% CI: 34.9% to 81.1%) to 90.8% (95% CI: 67.7% to 97.6%) for patients transplanted during 1990–2000 and 2001–2009, respectively. In multivariate analysis, transplant era significantly impacted OS (P=0.04), whereas age was only marginally significant (P=0.06, Cox proportional hazard analysis). No TRM occurred within the first 100 days among patients transplanted during 2001–2009 compared with 3/16 during 1990–2000, (P=0.03, Fisher's exact test). The extent of HLA mismatch did not significantly affect the incidence of acute GVHD, chronic GVHD or survival. Post-HCT autoimmune cytopenias were frequently diagnosed after 2001: 17/31 (55%) patients. Their occurrence was not associated with transplant donor type (P=0.53), acute GVHD (P=0.74), chronic GVHD (P=0.12), or post-transplant mixed chimerism (P=0.50).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA . A multi-institutional survey of the Wiskott Aldrich Syndrome. J Pediatr 1994; 125: 876–885.

    Article  CAS  Google Scholar 

  2. Ochs HD, Thrasher AJ . The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006; 117: 725–738.

    Article  CAS  Google Scholar 

  3. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M et al. Clinical course of patients with WASP gene mutations. Blood 2004; 103: 456–464.

    Article  CAS  Google Scholar 

  4. Parkman R, Rappeport J, Geha R, Belli J, Cassady R, Levey R et al. Complete correction of the Wiskott-Aldrich Syndrome by allogeneic bone-marrow transplantation. N Engl J Med 1978; 298: 921–927.

    Article  CAS  Google Scholar 

  5. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM . Bone marrow transplantation in a patient with the Wiskott Aldrich Syndrome. Lancet 1968; 292: 1362–1366.

    Article  Google Scholar 

  6. Ozsahin H, Le Deist F, Benkerrou M, Cavazzana-Calvo M, Gomez L, Griscelli C et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich Syndrome from a single center. J Pediatr 1996; 129: 238–244.

    Article  CAS  Google Scholar 

  7. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich Syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598–1603.

    Article  CAS  Google Scholar 

  8. Pai S-Y, DeMartiis D, Forino C, Cavagnini S, Lanfranchi A, Giliani S et al. Stem cell transplantation for the Wiskott-Aldrich Syndrome: a single center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant 2006; 38: 671–679.

    Article  Google Scholar 

  9. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  Google Scholar 

  10. Filipovich AH, Weisdorf D, Palvetic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  Google Scholar 

  11. Kaplan EL, Meier P . Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  12. Peto P, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II. Br J Cancer 1977; 35: 1–39.

    Article  CAS  Google Scholar 

  13. Cox DR . Regression models and life tables. J R Stat Soc 1972; 34: 187–200.

    Google Scholar 

  14. Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141–1154.

    Article  Google Scholar 

  15. Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD et al. Long term outcome and lineage- specific chimerism in 194 Wiskott-Aldrich syndrome patients treated by hematopoietic cell transplantation between 1980-2009: an international collaborative study. Blood 2011; 118: 1675–1684.

    Article  CAS  Google Scholar 

  16. Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 2008; 111: 439–445.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Special thanks to Denise Bellman, clinical research coordinator at CCHMC for her assistance with data collection. Additional thanks to Deborah Fearing and the Diagnostic Immunology Laboratory for immunologic analysis of samples.

Author Contributions: CR Shin researched and wrote the manuscript in collaboration with the senior author, AH Filipovich. M-O Kim and D Li performed the statistical analyses. R Harris, JJ Bleesing, P Mehta, S Jodele, MB Jordan, RA Marsh, SM Davies provided clinical care of the patients and commented on the contents and conclusions of the manuscript.

Author information

Authors and Affiliations

  1. Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

    C R Shin, J J Bleesing, R Harris, P Mehta, S Jodele, M B Jordan, R A Marsh, S M Davies & A H Filipovich

  2. Division of Biostatistics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

    M-O Kim & D Li

Authors
  1. C R Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M-O Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J J Bleesing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Jodele
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M B Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R A Marsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S M Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A H Filipovich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A H Filipovich.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, C., Kim, MO., Li, D. et al. Outcomes following hematopoietic cell transplantation for Wiskott–Aldrich syndrome. Bone Marrow Transplant 47, 1428–1435 (2012). https://doi.org/10.1038/bmt.2012.31

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.31

Keywords

This article is cited by

Search

Advanced search

Quick links